TNPH
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | 0.00 | $0 | — |
| 2024 Q4 | 0.00 | $0 | -$1,970 |
| 2024 Q3 | 0.00 | $0 | -$1,120 |
| 2024 Q2 | 0.00 | $0 | -$45 |
| 2024 Q1 | 0.00 | $0 | -$45 |
| 2023 Q4 | 0.00 | $110,474 | $5,383 |
| 2023 Q3 | -0.00 | $31,204 | -$11,624 |
| 2023 Q2 | -0.00 | $0 | -$6,611 |